Vivo Capital »

Inmed Pharmaceuticals shares owned by Vivo Capital

Quarter-by-quarter ownership of Inmed Pharmaceuticals (INM) shares owned by Vivo Capital from 13F filings

Historical chart of Vivo Capital investment in Inmed Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Inmed Pharmaceuticals held by Vivo Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Inmed Pharmaceuticals by Vivo Capital

Quarter filed Position value Share count Share price at filing
2026-06-30 $1.2M 798k 1.55

More positions owned by Vivo Capital

Trevi Therapeutics Common (TRVI)
Praxis Precision Medicines Common (PRAX)
Erasca Common (ERAS)
Arrivent BioPharma Common (AVBP)
Abivax SA - Sponsored Ads (ABVX)
Tango Therapeutics Common (TNGX)
Corvus Pharmaceuticals Common (CRVS)
Bright Minds Biosciences Common (DRUG)
Sinovac Biotech SHS
Tenax Therapeutics Common (TENX)
Aclaris Therapeutics Common (ACRS)
Dyne Therapeutics Common (DYN)
Dianthus Therapeutics Common (DNTH)
Alto Neuroscience Common (ANRO)
DBV Technologies SA Sponsored Ads (DBVT)

View all positions for Vivo Capital

Top funds holding Inmed Pharmaceuticals

ADAR1 Capital Management
Vivo Capital
Squadron Capital Management
Ikarian Capital
Ursa Fund Management
Suvretta Capital Management
Boothbay Fund Management
Sabby Management
Jane Street
VR Adviser
Citadel Advisors
Seven Grand Managers
Scientech Research
Crestwood Advisors
Two Sigma Securities

View all funds holding Inmed Pharmaceuticals